American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -296 | -240 | -1,028 | -615 | -413 |
| Depreciation Amortization | 97 | 49 | 207 | 159 | 112 |
| Accounts receivable | 59 | 60 | -88 | -202 | -168 |
| Accounts payable and accrued liabilities | 196 | 162 | -15 | 85 | -25 |
| Other Working Capital | 293 | 217 | 467 | 257 | 83 |
| Other Operating Activity | -205 | -196 | 237 | 145 | 245 |
| Operating Cash Flow | $144 | $52 | $-220 | $-171 | $-166 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | 0 | -22 | -21 | -13 |
| Other Investing Activity | 0 | 0 | -22 | -21 | -13 |
| Investing Cash Flow | $N/A | $0 | $-22 | $-21 | $-13 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,902 | 941 | 4,216 | 3,194 | 2,235 |
| Debt Issued | 48 | 48 | 63 | 150 | 150 |
| Debt Repayment | -81 | -78 | N/A | -84 | -81 |
| Other Financing Activity | -2,027 | -1,022 | -3,960 | -3,045 | -2,084 |
| Financing Cash Flow | $-158 | $-111 | $319 | $215 | $220 |
| Beginning Cash Position | 113 | 113 | 36 | 36 | 36 |
| End Cash Position | 99 | 54 | 113 | 59 | 76 |
| Net Cash Flow | $-14 | $-59 | $77 | $23 | $40 |
| Free Cash Flow | |||||
| Operating Cash Flow | 144 | 52 | -220 | -171 | -166 |
| Free Cash Flow | 144 | 52 | -220 | -171 | -166 |